Literature DB >> 12118164

Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies.

Tammy M Martin1, Justine R Smith, James T Rosenbaum.   

Abstract

Anterior uveitis describes inflammation that involves the iris or ciliary body. Anterior uveitis may be part of a systemic illness such as a spondyloarthropathy. It may also arise from an infection such as herpes simplex; be part of an ocular syndrome, such as Fuchs' heterochromic iridocyclitis; be part of trauma, as in cataract surgery; or result from an idiopathic eye disease with a presumed immune pathogenesis. During 2001, progress has been made understanding uveitis in general, as well as specifically, in association with spondyloarthropathy. Here, we review recent insights into anterior uveitis with regard to clinical presentation, immune mechanisms, genetics, and anti-tumor necrosis factor therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118164     DOI: 10.1097/00002281-200207000-00001

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  23 in total

Review 1.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Choroidal thickness changes determined by EDI-OCT on acute anterior uveitis in patients with HLA-B27-positive ankylosing spondylitis.

Authors:  Berna Basarir; Ugur Celik; Cigdem Altan; Nimet Burcu Celik
Journal:  Int Ophthalmol       Date:  2017-02-14       Impact factor: 2.031

Review 3.  Management of Uveitis in Spondyloarthropathy: Current Trends.

Authors:  Nikhil Gupta; Aditi Agarwal
Journal:  Perm J       Date:  2018

Review 4.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis.

Authors:  Serpil Yazgan; Ugur Celik; Metin Işık; Nesibe Karahan Yeşil; Ali Erdem Baki; Hatice Şahin; Ercan Gencer; İsmail Doğan
Journal:  Int Ophthalmol       Date:  2016-05-06       Impact factor: 2.031

6.  Characterization and outcome of uveitis in 350 patients with spondyloarthropathies.

Authors:  Percival D Sampaio-Barros; Roseneide A Conde; Rubens Bonfiglioli; Manoel B Bértolo; Adil M Samara
Journal:  Rheumatol Int       Date:  2006-09-07       Impact factor: 2.631

7.  Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry.

Authors:  Stefanie M Hauck; Johannes Dietter; Roxane L Kramer; Florian Hofmaier; Johanna K Zipplies; Barbara Amann; Annette Feuchtinger; Cornelia A Deeg; Marius Ueffing
Journal:  Mol Cell Proteomics       Date:  2010-07-04       Impact factor: 5.911

8.  Infliximab for the treatment of active scleritis.

Authors:  H Nida Sen; Amit Sangave; Keri Hammel; Grace Levy-Clarke; Robert B Nussenblatt
Journal:  Can J Ophthalmol       Date:  2009-06       Impact factor: 1.882

Review 9.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

10.  Interleukin-17 causes neutrophil mediated inflammation in ovalbumin-induced uveitis in DO11.10 mice.

Authors:  Zili Zhang; Wenwei Zhong; Doran Spencer; Hong Chen; Huiying Lu; Tatsushi Kawaguchi; James T Rosenbaum
Journal:  Cytokine       Date:  2009-02-28       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.